Curi RMB Capital’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.36M | Sell |
49,706
-885
| -2% | -$46.7K | 0.04% | 307 |
|
|
2025
Q4 | $2.65M | Sell |
50,591
-892
| -2% | -$53.4K | 0.05% | 296 |
|
|
2025
Q3 | $3.34M | Buy |
51,483
+66
| +0.1% | +$3.79K | 0.06% | 261 |
|
|
2025
Q2 | $2.5M | Buy |
51,417
+4,187
| +9% | +$162K | 0.05% | 294 |
|
|
2025
Q1 | $1.61M | Sell |
47,230
-1,831
| -4% | -$77.6K | 0.04% | 291 |
|
|
2024
Q4 | $1.93M | Buy |
49,061
+2,346
| +5% | +$111K | 0.04% | 270 |
|
|
2024
Q3 | $2.19M | Buy |
46,715
+7,597
| +19% | +$385K | 0.05% | 261 |
|
|
2024
Q2 | $2.11M | Buy |
39,118
+4,804
| +14% | +$278K | 0.05% | 259 |
|
|
2024
Q1 | $2.34M | Buy |
34,314
+2,804
| +9% | +$201K | 0.05% | 254 |
|
|
2023
Q4 | $1.97M | Buy |
31,510
+92
| +0.3% | +$5.09K | 0.06% | 233 |
|
|
2023
Q3 | $1.43M | Sell |
31,418
-152
| -0.5% | -$7.85K | 0.05% | 252 |
|
|
2023
Q2 | $1.77M | Hold |
31,570
| – | – | 0.06% | 236 |
|
|
2023
Q1 | $1.43M | Buy |
31,570
+4,835
| +18% | +$235K | 0.05% | 251 |
|
|
2022
Q4 | $1.09M | Sell |
26,735
-9,496
| -26% | -$504K | 0.04% | 274 |
|
|
2022
Q3 | $2.37M | Hold |
36,231
| – | – | 0.09% | 209 |
|
|
2022
Q2 | $2.2M | Sell |
36,231
-3,795
| -9% | -$223K | 0.08% | 210 |
|
|
2022
Q1 | $2.51M | Buy |
40,026
+6,629
| +20% | +$416K | 0.08% | 177 |
|
|
2021
Q4 | $2.53M | Buy |
33,397
+11,148
| +50% | +$974K | 0.08% | 179 |
|
|
2021
Q3 | $2.49M | Buy |
22,249
+6
| +0% | +$754 | 0.08% | 185 |
|
|
2021
Q2 | $3.6M | Buy |
22,243
+10,981
| +98% | +$1.34M | 0.12% | 154 |
|
|
2021
Q1 | $1.37M | Buy |
11,262
+8,362
| +288% | +$1.26M | 0.05% | 225 |
|
|
2020
Q4 | $444K | Hold |
2,900
| – | – | 0.02% | 442 |
|
|
2020
Q3 | $243K | Hold |
2,900
| – | – | 0.01% | 531 |
|
|
2020
Q2 | $213K | Buy |
+2,900
| New | +$170K | 0.01% | 536 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
